These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3367903)

  • 1. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate.
    Selinsky BS; Perlman ME; London RE
    Mol Pharmacol; 1988 May; 33(5):559-66. PubMed ID: 3367903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. II. A reevaluation of hepatic metabolic pathways.
    Selinsky BS; Perlman ME; London RE
    Mol Pharmacol; 1988 May; 33(5):567-73. PubMed ID: 3367904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cimetidine on anesthetic metabolism and toxicity.
    Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ
    Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phenytoin (DPH) treatment on methoxyflurane metabolism in rats.
    Caughey GH; Rice SA; Kosek JC; Mazze RI
    J Pharmacol Exp Ther; 1979 Aug; 210(2):180-5. PubMed ID: 458627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of age on the distribution, metabolism and excretion of methoxyflurane in Fischer 344 rats: a possible relationship to nephrotoxicity.
    Bell LE; Hitt BA; Mazze RI
    J Pharmacol Exp Ther; 1975 Oct; 195(1):34-40. PubMed ID: 241841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 1): Identification of the nephrotoxic metabolic pathway.
    Kharasch ED; Schroeder JL; Liggitt HD; Park SB; Whittington D; Sheffels P
    Anesthesiology; 2006 Oct; 105(4):726-36. PubMed ID: 17006072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and urine inorganic fluoride concentrations and urine oxalate concentrations following methoxyflurane anesthesia in the dog.
    Brunson DB; Stowe CM; McGrath CJ
    Am J Vet Res; 1979 Feb; 40(2):197-203. PubMed ID: 464357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of nephrotoxic haloalkanes.
    Kluwe WM; Hook JB
    Fed Proc; 1980 Nov; 39(13):3129-33. PubMed ID: 7428957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome P450 2E1 in the metabolism of 1,1,2,3,3,3-hexafluoropropyl methyl ether.
    Köster U; Speerschneider P; Kerssebaum R; Wittmann H; Dekant W
    Drug Metab Dispos; 1994; 22(5):667-72. PubMed ID: 7835215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
    Dekant W; Assmann M; Urban G
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation of glucose metabolism in the rat liver by in vivo 13C MR spectroscopy without proton decoupling.
    Nakakoshi T
    Radiat Med; 1995; 13(4):195-7. PubMed ID: 8539449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
    Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
    NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I-653 resists degradation in rats.
    Koblin DD; Eger EI; Johnson BH; Konopka K; Waskell L
    Anesth Analg; 1988 Jun; 67(6):534-8. PubMed ID: 3377207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the mechanism of methoxyflurane nephrotoxicity and implications for anesthetic development (part 2): Identification of nephrotoxic metabolites.
    Kharasch ED; Schroeder JL; Liggitt HD; Ensign D; Whittington D
    Anesthesiology; 2006 Oct; 105(4):737-45. PubMed ID: 17006073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic drug metabolism and anesthesia.
    Poppers PJ
    Anaesthesist; 1980 Feb; 29(2):55-8. PubMed ID: 6990824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
    Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
    Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver regeneration after partial hepatectomy in the rat. Sequential events monitored by 31P-nuclear magnetic resonance spectroscopy and biochemical studies.
    Farghali H; Rilo H; Zhang W; Simplaceanu V; Gavaler JS; Ho C; van Thiel DH
    Lab Invest; 1994 Mar; 70(3):418-25. PubMed ID: 8145535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inorganic fluoride and renal function in dogs after methoxyflurane anesthesia, tetracycline treatment, and surgical manipulation.
    Fleming JT; Pedersoli WM
    Am J Vet Res; 1980 Dec; 41(12):2025-9. PubMed ID: 7212437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of methoxyflurane: release of inorganic fluoride in human and rat hepatic microsomes.
    Van Dyke RA; Wood CL
    Anesthesiology; 1973 Dec; 39(6):613-8. PubMed ID: 4761020
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.